Protocol summary

Study aim
The effect of davayebalgham capsule and acupuncture on blood sugar and lipid profile of type ۲ diabetic patients
Design
A clinical trial with a control group, with parallel groups, single-blind, randomized, phase 3 on 105 patients. randomization with blocks of three is used by statistical software (SPSS).
Settings and conduct
Sampling will be done among the patients referred to the clinics affiliated with Tabriz University of Medical Sciences. After referring the candidates, a complete history is taken from them and the entry and exit criteria are evaluated. If they agree to participate in the project, the candidates will be randomly divided into three groups. Group one: herbal medicine, group two: placebo, and group three: will undergo acupuncture. Then the studied variables are recorded at the beginning of entering the design. At the beginning and end of 12 weeks, biochemical parameters are measured and recorded through a blood test after at least 12 hours of fasting by taking 8 cc of blood and other variables. In order to perform acupuncture, stimulation of st40, sp6, Li11, sj5, st25, Lu7, du20, ren4, ren17, and ren12 points will be made for 20 minutes with a size of 25 x 40. (once a week for 12 weeks)
Participants/Inclusion and exclusion criteria
Patients with type 2 diabetes without specific underlying disease in the age range of 20 to 65 years
Intervention groups
1- davayebalgham product receiving group 2- Placebo, davayebalgham product receiving group 3- Acupuncture receiving group
Main outcome variables
Fasting blood sugar؛ Cholesterol؛ Triglycerides

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220502054721N1
Registration date: 2022-10-22, 1401/07/30
Registration timing: registered_while_recruiting

Last update: 2022-10-22, 1401/07/30
Update count: 0
Registration date
2022-10-22, 1401/07/30
Registrant information
Name
maryam rahimzade
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8897 4535
Email address
m-rahimzade@razi.tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-07-23, 1401/05/01
Expected recruitment end date
2023-03-20, 1401/12/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of davayebalgham capsule (a Persian medicine product) and acupuncture on blood sugar and lipid profile of type 2 diabetic patients (a randomized clinical study)
Public title
The effect of davayebalgham capsule and acupuncture on type 2 diabetic patients
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Type 2 Diabetes patients Taking oral hypoglycemic drugs Age 20-65 years Satisfaction to enter the plan HbA۱C < %۹
Exclusion criteria:
Having serious gastrointestinal diseases including active stomach ulcers and gastrointestinal bleeding History of diabetic ketoacidosis, non-ketone hyperosmolar diabetic coma, severe infection or surgery in the previous month Kidney failure, liver dysfunction, cancers, cysts or breast mass, metabolic diseases Having a psychological illness Consumption of alcohol, drugs or psychotropic substances Uncontrolled hypertension (blood pressure greater than or equal to 100/160 mm Hg) History of myocardial infarction Taking anticoagulants (warfarin and Plavix ...) Insulin therapy over the past three months Continued use of herbs or other herbal medicines Fasting blood sugar above 180 Pregnancy, breastfeeding Having allergies to any of the plants
Age
From 20 years old to 65 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
Sample size
Target sample size: 105
Randomization (investigator's opinion)
Randomized
Randomization description
Participants are divided into three groups in a random triple block (by SPSS software). They receive a group of herbal medicine, a group placebo of herbal medicine, and a group of acupuncture. After consenting to participate in the plan, people are randomly placed in one of the mentioned groups.
Blinding (investigator's opinion)
Single blinded
Blinding description
Patients are unaware that they are in the herbal intervention or placebo group.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tehran University of Medical Sciences
Street address
No. 27، North Sarparsat Street، at the beginning of West Taleghani Street، Palestine Square
City
Tehran
Province
Tehran
Postal code
1416663361
Approval date
2022-02-21, 1400/12/02
Ethics committee reference number
IR.TUMS.MEDICINE.REC.1400.1379

Health conditions studied

1

Description of health condition studied
Type 2 diabetes
ICD-10 code
E11
ICD-10 code description
Type 2 diabetes mellitus

Primary outcomes

1

Description
Fasting blood sugar
Timepoint
The beginning of the study, 3 months later
Method of measurement
laboratory kit

2

Description
Blood cholesterol
Timepoint
The beginning of the study, 3 months later
Method of measurement
Laboratory kit (blood test)

3

Description
Blood triglycerides
Timepoint
The beginning of the study, 3 months later
Method of measurement
Laboratory kit (blood test)

Secondary outcomes

1

Description
HbA۱C
Timepoint
The beginning of the study, 3 months later
Method of measurement
Laboratory kit (blood test)

Intervention groups

1

Description
Intervention group: Davaebalgham product. After the raw materials of this formulation including mastic gum, Trachyspermum ammi (L.) Sprague, Nigella sativa L and Zataria multiflora Boiss were obtained from the market of medicinal plants, a sample of plants was identified and A herbarium code is assigned to each sample. The quality control of the raw materials was done and the plants were ground and mixed with equal proportions of the powders of four plants. The mixed powder of four plants is formulated in the form of 500 mg hard gelatin capsules, so that each patient will receive 2.5 grams of the mixed plant powder in the form of medicinal capsules. For this purpose, each participant will receive the desired dose in 6 capsules of 500 mg (2 after breakfast, 2 after lunch and 2 after dinner) for 12 weeks.
Category
Treatment - Drugs

2

Description
Control group: Davaebalgham placebo.Placebo capsules will be filled with avicel and toast powder, and in order to match the color and smell of the content inside the capsules, edible colors and a very small percentage of essential oil will be used. Standardization of the product will be done by determining the amount of thymol by gas chromatography-mass spectrometry and determining the amount of total phenol.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Asadabadi Hospital
Full name of responsible person
Maryam Rahimzade
Street address
Bahar Street
City
Tabriz
Province
East Azarbaijan
Postal code
5169664343
Phone
+98 41 3384 2624
Email
rahimzademaryam2@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Akbar Fotuhi
Street address
Tehran University of Medical Sciences, Enghelab Street
City
Tehran
Province
Tehran
Postal code
1417613151
Phone
+98 21 8897 8745
Email
info@tpcf.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Maryam Rahimzade
Position
Assistant
Latest degree
Medical doctor
Other areas of specialty/work
Traditional Medicine
Street address
Ahmadiye Building, No. 27, North Sarparast Ave, Western Taleghani Ave, Felestin Square, Tehran Town
City
Tehran
Province
Tehran
Postal code
1416663361
Phone
+98 21 8897 4535
Fax
Email
m-rahimzade@razi.tums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Amir Hooman Kazemi
Position
professor
Latest degree
Subspecialist
Other areas of specialty/work
Traditional Medicine
Street address
Ahmadiye Building, No. 27, North Sarparast Ave, Western Taleghani Ave, Felestin Square, Tehran Town
City
Tehran
Province
Tehran
Postal code
1416663361
Phone
+98 21 8897 4535
Fax
Email
amirhoomank@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Maryam Rahimzade
Position
Assistant
Latest degree
Medical doctor
Other areas of specialty/work
Traditional Medicine
Street address
Ahmadiye Building, No. 27, North Sarparast Ave, Western Taleghani Ave, Felestin Square, Tehran Town
City
Tehran
Province
Tehran
Postal code
1416663361
Phone
+98 21 8897 4535
Fax
Email
m-rahimzade@razi.tums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Title and more details about the data/document
The collected data are published in the form of an article after analysis.
When the data will become available and for how long
After publishing the results
To whom data/document is available
Everyone (depending on magazine policies)
Under which criteria data/document could be used
The published study will be public
From where data/document is obtainable
The journal in which the article was published Author's Email: maryam rahimzade m-rahimzade@razi.tums.ac.ir
What processes are involved for a request to access data/document
After sending the email to the responsible author, the email will be answered within one month at most.
Comments
Loading...